Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents

被引:7
|
作者
Omran, Ziad [1 ]
Guise, Chris P. [2 ]
Chen, Linwei [3 ]
Rauch, Cyril [4 ]
Abdalla, Ashraf N. [5 ]
Abdullah, Omeima [5 ]
Sindi, Ikhlas A. [6 ]
Fischer, Peter M. [7 ]
Smaill, Jeff B. [2 ]
Patterson, Adam V. [2 ]
Liu, Yuxiu [3 ]
Wang, Qingmin [3 ]
机构
[1] Batterjee Med Coll, Dept Pharmaceut Sci, Dept Pharm, Jeddah 21442, Saudi Arabia
[2] Univ Auckland, Sch Med Sci, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland 1142, New Zealand
[3] Nankai Univ, Res Inst Elementoorgan Chem, Coll Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China
[4] Univ Nottingham, Sch Vet Med & Sci, Coll Rd, Loughborough LE12 5RD, England
[5] Umm Al Qura Univ, Coll Pharm, Mecca 21955, Saudi Arabia
[6] King Abdulaziz Univ, Dept Biol, Fac Sci, Jeddah 21589, Saudi Arabia
[7] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England
来源
MOLECULES | 2021年 / 26卷 / 11期
关键词
phenanthroindolizidine; antofine; tylophorine; hypoxia; prodrugs; solid tumors; PHENANTHROINDOLIZIDINE ALKALOIDS PERGULARININE; QUATERNARY AMMONIUM PRODRUGS; CELL-GROWTH; THYMIDYLATE SYNTHASE; DRUG-RESISTANCE; TUMOR HYPOXIA; CANCER; INHIBITION; CYTOTOXICITY; ANGIOGENESIS;
D O I
10.3390/molecules26113327
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phenanthroindolizidines, such as antofine and tylophorine, are a family of natural alkaloids isolated from different species of Asclepiadaceas. They are characterized by interesting biological activities, such as pronounced cytotoxicity against different human cancerous cell lines, including multidrug-resistant examples. Nonetheless, these derivatives are associated with severe neurotoxicity and loss of in vivo activity due to the highly lipophilic nature of the alkaloids. Here, we describe the development of highly polar prodrugs of antofine and tylophorine as hypoxia-targeted prodrugs. The developed quaternary ammonium salts of phenanthroindolizidines showed high chemical and metabolic stability and are predicted to have no penetration through the blood-brain barrier. The designed prodrugs displayed decreased cytotoxicity when tested under normoxic conditions. However, their cytotoxic activity considerably increased when tested under hypoxic conditions.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Synthesis and biological evaluation of FUDR monophosphate prodrugs as anticancer agents
    Gonczy, Blanka
    Slusarczyk, Magdalena
    Murziani, Paola
    McGuigan, Christopher
    Vande Voorde, Johan
    Liekens, Sandra
    Balzarini, Jan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [2] Design, Synthesis and in Vitro Evaluation of Tylophorine Derivatives as Possible Antitumor Agents
    Mang, Zhiguo
    Zhang, Shuai
    Bai, Jing
    Li, Meijuan
    Li, Hao
    CHEMISTRY & BIODIVERSITY, 2020, 17 (09)
  • [3] Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
    O'Connor, Liam J.
    Cazares-Koerner, Cindy
    Saha, Jaideep
    Evans, Charles N. G.
    Stratford, Michael R. L.
    Hammond, Ester M.
    Conway, Stuart J.
    NATURE PROTOCOLS, 2016, 11 (04) : 781 - 794
  • [4] Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
    Liam J O'Connor
    Cindy Cazares-Körner
    Jaideep Saha
    Charles N G Evans
    Michael R L Stratford
    Ester M Hammond
    Stuart J Conway
    Nature Protocols, 2016, 11 : 781 - 794
  • [5] Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides
    McGuigan, Christopher
    Bourdin, Claire
    Derudas, Marco
    Hamon, Nadege
    Hinsinger, Karen
    Kandil, Sahar
    Madela, Karolina
    Meneghesso, Silvia
    Pertusati, Fabrizio
    Serpi, Michaela
    Slusarczyk, Magdalena
    Chamberlain, Stanley
    Kolykhalov, Alexander
    Vernachio, John
    Vanpouille, Christophe
    Introini, Andrea
    Margolis, Leonid
    Balzarini, Jan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 326 - 340
  • [6] Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
    Adawy, Heba A.
    Tawfik, Samar S.
    Elgazar, Abdullah A.
    Selim, Khalid B.
    Goda, Fatma E.
    RSC ADVANCES, 2024, 14 (48) : 35239 - 35254
  • [7] Design, synthesis, biological evaluation, and mechanism of action of new pyrazines as anticancer agents in vitro and in vivo
    Lan, Jin-Xia
    Huang, Le-Jun
    Kang, Si-Shuang
    Liu, Sheng-Lan
    Dai, Wei
    Xu, Xin-Liang
    Wang, Jin-Yang
    Shu, Guang-Zhao
    Hou, Wen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 121
  • [8] Design, synthesis and biological evaluation of rhein derivatives as anticancer agents
    Huang, Junkai
    Zhang, Zhuo
    Huang, Peng
    He, Liqin
    Ling, Yong
    MEDCHEMCOMM, 2016, 7 (09) : 1812 - 1818
  • [9] Design, synthesis, biological evaluation, and molecular docking of novel quinazolinone EGFR inhibitors as targeted anticancer agents
    Nofal, Zinab M.
    Amin, Kamelia M.
    Mohamed, Hanaa S.
    El-Kerdawy, Ahmed M.
    Aly, Magdy S.
    Habib, Basma S.
    Sarhan, Alaadin E.
    SYNTHETIC COMMUNICATIONS, 2022, 52 (18) : 1805 - 1824
  • [10] Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy
    Gerard, Yvain
    Voissiere, Aurelien
    Peyrode, Caroline
    Galmier, Marie-Josephe
    Maubert, Elise
    Ghedira, Donia
    Tarrit, Sebastien
    Gaumet, Vincent
    Canitrot, Damien
    Miot-Noirault, Elisabeth
    Chezal, Jean-Michel
    Weber, Valerie
    BIOORGANIC CHEMISTRY, 2020, 98